Plasma F 2-isoprostanes are elevated in newborns and inversely correlated to gestational age

Free Radical Biology and Medicine

Volumn 37, Issue 5, 2004, Pages 724-732

  Comporti, Mario ^a   Signorini, Cinzia ^a   Leoncini, Silvia ^a   Buonocore, Giuseppe ^a   Rossi, Viviana ^a   Ciccoli, Lucia ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

BHT; butylated hydroxytoluene; C 18; CP22; Erythrocyte iron release; Free radicals; Newborns; Non protein bound iron; octadecylsilane; Oxidative stress; Placental F 2 isoprostanes; Plasma F 2 isoprostanes

Indexed keywords

DEFEROXAMINE; IRON; ISOPROSTANE; BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; ERYTHROCYTE; FEMALE; GAS CHROMATOGRAPHY; GESTATIONAL AGE; HUMAN; INCUBATION TIME; IRON CHELATION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MOTHER; NEWBORN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; STATISTICAL SIGNIFICANCE; BIRTH WEIGHT; BLOOD; MASS FRAGMENTOGRAPHY;

BIOLOGICAL MARKERS; BIRTH WEIGHT; F2-ISOPROSTANES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE;

EID: 3342953930     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.06.007     Document Type: Article

References (76)

1. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1:1987;358-364
2. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 1989;Clarendon Press, Oxford
3. Southorn P.A., Powis G. Free radicals in medicine. I. Chemical nature and biological reactions. II. Involvement in human disease. Mayo Clin. Proc. 63:1988;381-408
4. Esterbauer H., Schauer R.J., Zollne H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128
5. Morrow J.D., Harris T.M., Roberts L.J. II Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184:1990;1-10
6. 2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Packer L. Methods in enzymology, Vol. 233, Oxygen radicals in biological systems, Part C. 1994;163-179 Academic Press, San Diego
7. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation. J. Clin. Invest. 90:1992;2502-2507
8. Longmire A.W., Swift L.L., Roberts L.J. II, Awad J.A., Burk R.F., Morrow J.D. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem. Pharmacol. 47:1994;1173-1177
9. 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA. 89:1992;10721-10725
10. Morrow J.D., Roberts L.J. II The isoprostanes: current knowledge and directions for future research. Biochem. Pharmacol. 51:1996;1-9
11. Delanty N., Reilly M., Pratico D., FitzGerald D.J., Lawson J.A., FitzGerald G.A. 8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br. J. Clin. Pharmacol. 42:1996;15-19
12. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 99:1999;224-229
13. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368:1995;225-229
14. Nanji A.A., Khwaja S., Tahan S.R., Sadrzadeh S.M. Plasma levels of a novel non-cyclooxygenase derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J. Pharmacol. Exp. Ther. 269:1994;1280-1285
15. Carpenter C.T., Price P.V., Christman B.W. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest. 114:1998;1653-1659
16. Montine T.J., Markesbery W.R., Morrow J.D., Roberts L.J. II Cerebrospinal fluid F2-isoprostane levels are increased with Alzheimer's disease. Ann. Neurol. 44:1998;410-413
17. Montine T.J., Beal M.F., Cudkowicz M.E., O'Donnel H., Margolin R.A., McFarland L., Bachrach A.F., Zackert W.E., Roberts L.J. II, Morrow J.D. Increased CSF F2-isoprostane concentration in probable AD. Neurology. 52:1999;562-565
18. Pratico D., My Lee V., Trojanowski J.Q., Rokach J., FitzGerald G.A. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 12:1998;1777-1783
19. 2α, on retinal vessels. Am.J. Physiol. 274:1998;R1406-R1416
20. Saugstad O.D. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Pædiatr. 85:1996;1-4
21. Phylactos A.C., Leaf A.A., Costeloe K., Crawford M.A. Erythrocyte cupric/zinc superoxide dismutase exhibits reduced activity in preterm and low birthweight infants at birth. Acta Pædiatr. 84:1995;1421-1425
22. Frank L., Sosenko R.S. Development of lung antioxidant enzyme system in late gestation: possible implications for the prematurely born infant. J. Pediatr. 110:1987;9-14
23. Haga P., Lunde G. Selenium and vitamin E in cord blood from preterm and full-term infants. Acta Pædiatr. Scand. 67:1978;735-739
24. Lindeman J.H.N., Lentjes E.G.W.M., van Zoeren-Grobben D., Berger H.M. Postnatal changes in plasma ceruloplasmin and transferrin antioxidant activities in preterm babies. Biol. Neonate. 78:2000;73-76
25. Berger H.M., Mumby S., Gutteridge J.M.C. Ferrous ions detected in iron-overload cord blood plasma from preterm and term babies: implications for oxidative stress. Free Radic. Res. 22:1995;555-559
26. Dorrepaal C.A., Berger H.M., Benders M.J., van Zoeren-Grobben D., Van de Bor M., Van Bel F. Nonprotein-bound iron in postasphyxial reperfusion injury of the newborn. Pediatrics. 98:1996;883-889
27. Loreal O., Gosriwatana I., Guyader D., Porter J., Brissot P., Hider R.C. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J. Hepatol. 32:2000;727-733
28. al-Refaie F.N., Wickens D.G., Wonke B., Kontoghiorghes G.J., Hoffbrand A.V. Serum non-transferrin-bound iron in beta-thalassemia major patients treated with desferrioxamine and L1. Br. J. Haematol. 82:1992;431-436
29. Berger H.M., Moison R.M., Van Zoeren-Grobben D., Conneman N., Geerdink J. Pro-oxidant effects of iron in the newborn period. Ziegler E.E., Lucas A., Moro G.E. Nutrition of the very low-birthweight infant. 1999;121-137 Lippincott Williams Wilkins, Philadelphia
30. Pearson H.A. Life span of the fetal red blood cell. J. Pediatr. 70:1967;166-171
31. Jain S.K. The neonatal erythrocyte and its oxidative susceptibility. Semin. Hematol. 26:1989;286-300
32. Shahal Y., Bauminger E.R., Zmora E., Katz M., Mazor D., Horn S., Meyerstein N. Oxidative stress in newborn erythrocytes. Pediatr. Res. 29:1991;119-122
33. Lubin B.H., van den Berg J.J.M., Lewis R.A., Scott M.D., Kuypers F.A. Unique properties of the neonatal red cell. Xanthou M., Bracci R., Prindull G. Neonatal haematology and immunology II. 1993;79-89 Excerpta Medicam, Amsterdam
34. Martin H., Huisman T.H. Formation of ferrihaemoglobin of isolated human haemoglobin types by sodium nitrate. Nature. 200:1963;898-899
35. Ferrali M., Ciccoli L., Signorini C., Comporti M. Iron release and erythrocyte damage in allyl alcohol intoxication mice. Biochem. Pharmacol. 40:1990;1484-1490
36. Ferrali M., Signorini C., Ciccoli L., Comporti M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem. J. 285:1992;295-301
37. Ciccoli L., Ferrali M., Rossi V., Signorini C., Alessandrini C., Comporti M. Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver. Toxicol. Lett. 110:1999;57-66
38. Signorini C., Ferrali M., Ciccoli L., Sugherini L., Magnani A., Comporti M. Iron release, membrane protein oxidation and erythrocyte ageing. FEBS Lett. 362:1995;165-170
39. Buonocore G., Zani S., Sargentini I., Gioia D., Signorini C., Bracci R. Hypoxia-induced free iron release in the red cells of newborn infants. Acta Pædiatr. 87:1998;77-81
40. Nourooz-Zadeh J., Gopaul N.K., Barrow S., Mallet A.I., Änggård E.E. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J. Chromatogr. B. 667:1995;199-208
41. Nourooz-Zadeh J. Gas chromatography-mass spectrometry assay for measurement of plasma isoprostanes. Packer L. Methods in enzymology, Vol. 300, Oxidants and antioxidants, B. Part. 1999;13-17 Academic Press, San Diego
42. 2-isoprostanes. J. Mass Spectrom. 38:2003;1067-1074
43. Nourooz-Zadeh J., Liu E.H.C., Yhlen B., Änggård E.E., Halliwell B. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J. Neurochem. 72:1999;734-740
44. Singh S., Hider R.C., Porter J.B. A direct method for quantification of non-transferrin-bound iron. Anal. Biochem. 186:1990;320-323
45. Kime R., Gibson A., Yong W., Hider R., Powers H. Chromatographic method for the determination of non-transferrin-bound iron suitable for use on the plasma and bronchoalveolar lavage fluid of preterm babies. Clin. Sci. 91:1996;633-638
46. Ferrali M., Ciccoli L., Comporti M. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem. Pharmacol. 38:1989;1819-1825
47. Comporti M. Three models of free radical-induced cell injury. Chem. Biol. Interact. 72:1989;1-56
48. Comporti M. Lipid peroxidation as a mediator of chemical-induced hepatocyte death. Plaa G.L., Hewitt W.R. Toxicology of the liver. 2nd ed.:1998;221-257 Taylor & Francis, London
49. Comporti M., Saccocci C., Dianzani M.U. Effect of CCl4 in vitro and in vivo on lipid peroxidation of rat liver homogenates and subcellular fractions. Enzymologia. 29:1965;185-204
50. Bracci R., Buonocore G. The antioxidant status of erythrocytes in preterm and term infants. Semin. Neonatol. 3:1998;191-197
51. Saugstad O.D. Oxygen toxicity in the neonatal period. Acta Pædiatr. Scand. 79:1990;881-892
52. Buonocore G., Perrone S., Bracci R. Free radicals and brain damage in the newborn. Biol. Neonate. 79:2001;180-186
53. Gordon H.H., Nitowsky H.M., Cornblath M. Studies of tocopherol deficiency in infants and children. I. Hemolysis of erythrocytes in hydrogen peroxide. Am. J. Dis. Child. 90:1955;669-681
54. Ripalda M.J., Rudolph N., Wong S.L. Developmental patterns of antioxidant defense mechanisms in human erythrocytes. Pediatr. Res. 26:1989;366-369
55. Buonocore G., Zani S., Perrone S., Caciotti B., Bracci R. Intraerythrocyte nonprotein-bound iron and plasma malondialdehyde in the hypoxic newborn. Free Radic. Biol. Med. 25:1998;766-770
56. Inder T.E., Graham P., Sanderson K., Taylor B.J. Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant. Arch. Dis. Child Fetal Neonatal Ed. 70:1994;F107-F111
57. Schmidt H., Grune T., Muller R., Siems W.G., Wauer R.R. Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia. Pediatr. Res. 40:1996;15-20
58. Sekiba K., Yoshioka T. Changes of lipid peroxidation and superoxide dismutase activity in the human placenta. Am. J. Obstet. Gynecol. 135:1979;368-371
59. Serdar Z., Gür E., Develioglu O., Colakogullari M., Dirican M. Placental and decidual lipid peroxidation and antioxidant defenses in preeclampsia: lipid peroxidation in preeclampsia. Pathophysiology. 9:2002;21-25
60. Walsh S.W., Wang Y., Jesse R. Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. Hypertens. Pregnancy. 15:1996;101-111
61. Walsh S.W. Lipid peroxidation in pregnancy. Hypertens. Pregnancy. 13:1994;1-32
62. 2α in the decidua basalis of women with preeclampsia. Am. J. Obstet. Gynecol. 181:1999;1211-1215
63. Walsh S.W., Vaughan J.E., Wang Y., Roberts L.J. II Placental isoprostanes is significantly increased in preeclampsia. FASEB J. 14:2000;1289-1296
64. Rogers M.S., Mongelli M., Tsang K.H., Wang C.C. Fetal and maternal levels of lipid peroxides in term pregnancies. Acta Obstet. Gynecol. Scand. 78:1999;120-124
65. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. II A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free-radical catalysed mechanism. Proc. Natl. Acad. Sci. USA. 87:1990;9383-9387
66. 2 receptors. J. Clin. Invest. 90:1992;136-141
67. 2α in isolated perfused rat lung. J. Appl. Physiol. 74:1993;460-465
68. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 264:1993;C1619-C1624
69. Ogletree M.L., Harris D.N., Greenberg R., Haslanger M.F., Nakane M. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J. Pharmacol. Exp. Ther. 234:1985;435-441
70. Reynaud X., Dorey C.K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest. Ophthalmol. Visual Sci. 35:1994;3169-3177
71. Phelps D.L., Rosenbaum A.L. Effects of marginal hypoxemia on recovery from oxygen induced retinopathy in the kitten model. Pediatrics. 73:1984;1-6
72. 2 involvement in diabetic retinopathy. Metab. Pediatr. Syst. Ophthalmol. 6:1982;321-325
73. 2α in rabbit lung in situ. Am. J. Physiol. 263:1992;H660-H663
74. Hoffman S.W., Moore S., Ellis E.F. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke. 28:1997;844-849
75. Berger T.M., Polidori M.C., Dabbagh A., Evans P.J., Halliwell B., Morrow J.D., Roberts L.J. II, Frei B. Antioxidant activity of vitamin C in iron-overloaded human plasma. J. Biol. Chem. 272:1997;15656-15660
76. Ciccoli L., Rossi V., Leoncini S., Signorini C., Paffetti P., Bracci R., Buonocore G., Comporti M. Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns. Free Radic. Res. 37:2003;51-58